Germany’s vaccine commission said AstraZeneca’s COVID-19 vaccine should not be used on people 65 and older due to “insufficient data” on its efficacy.
The Standing Vaccine Commission said the shot, which is being developed with the University of Oxford, should only be used on people aged 18 to 64 “based on available data.”
“There is currently insufficient data to assess the efficacy of the vaccine for persons aged 65 years and older,” the panel of scientific experts said.
The recommendation follows confusion earlier this week over the efficacy of AstraZeneca’s jab in adults over 65.
Two German newspapers, citing government sources, said the shot was found to be as low as 8 percent effective in seniors — which the UK-based company said was “completely incorrect,” German broadcaster Deutsch Welle reported on Tuesday.
“In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100% of older adults generating spike-specific antibodies after the second dose,” AstraZeneca’s spokesperson said.